KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+86-022-82164980
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
| Catalog Number | YR1265 |
|---|---|
| Product Name | Anti-Human VWF A1 domain Recombinant Antibody |
| Molecular Name | Caplacizumab |
| Alias | Anti-VWF A1 domain Recombinant Antibody, Research Grade Caplacizumab |
| CAS Number | 915810-67-2 |
| Molecular Weight | 27.88 kDa |
| Target | VWF A1 domain[Homo sapiens] |
| Isotype | VH-VH |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Background | Caplacizumab (INN, trade name Cablivi) is a bivalent single-domain antibody (VHH) designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
Hot Line： +86-022-82164980
Technical Support：[email protected]
